Changes in the epidemic patterns of respiratory pathogens of children in guangzhou, China during the COVID-19 pandemic.

IF 3 3区 医学 Q2 INFECTIOUS DISEASES
De-Feng Liang, Wen-Lin Guo, Dan-Ping Zhu, Su-Yun Li, Wei-Dong Zhu, Ying Li, Li Huang, Jun Shen, Pei-Qing Li
{"title":"Changes in the epidemic patterns of respiratory pathogens of children in guangzhou, China during the COVID-19 pandemic.","authors":"De-Feng Liang, Wen-Lin Guo, Dan-Ping Zhu, Su-Yun Li, Wei-Dong Zhu, Ying Li, Li Huang, Jun Shen, Pei-Qing Li","doi":"10.1186/s12879-025-11215-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the epidemiological characteristics of pediatric respiratory pathogens in Guangzhou, China, from 2018 to 2023 in the context of the COVID-19 Pandemic and to evaluate the impact of non-pharmaceutical interventions (NPIs) on the transmission dynamics and seasonal patterns of respiratory pathogens.</p><p><strong>Methods: </strong>A retrospective analysis was conducted at Guangzhou Women and Children's Medical Center between January 2018 and December 2023. Pediatric patients who underwent the respiratory pathogens tests were enrolled in the study and divided into four groups by age: Infant group, Toddler group, Preschool group, and School-age group. The nasopharyngeal swab or bronchoalveolar lavage fluid (BALF) samples were collected for real-time fluorescence quantitative polymerase chain reaction (qPCR) test of respiratory pathogens. Ten common respiratory pathogens, including respiratory syncytial virus (RSV), Mycoplasma pneumoniae (MP) and Influenza A virus (FluA), were detected. In addition, the study period was divided into three phases: Pre-COVID-19 (2018-2019), COVID-19 (2020-2022), and Post-COVID-19 (2023). Detection rates, distribution patterns, and seasonal variations of respiratory pathogens were analyzed between different phases and different age groups.</p><p><strong>Results: </strong>This study included 317,828 pediatric patients (median age: 3.4 years, IQR: 1.3-6.0), from whom 1,160,764 respiratory pathogen tests were conducted. The overall pathogen detection rate was 8.02% (93,108/1,160,764). The positive rate during the COVID-19 phase (18.44%, 95% CI 14.89-22.00%) was significantly lower than that of the Pre-COVID-19 (27.55%, 95% CI 23.95-31.16%) and Post-COVID-19 (27.15, 95% CI 21.47-32.84%) phases (P < 0.001). No significant difference was observed between Pre-COVID-19 and Post-COVID-19 phases (P = 0.948). Different pathogens exhibited varying levels of suppression and recovery patterns, with some demonstrating altered seasonal patterns. The primary affected age groups shifted from infants and toddlers during the Pre-COVID-19 and COVID-19 phases to preschool and school-age children in the Post-COVID-19 phase. Co-infections were identified in 2,515 cases, with the highest rate observed during the Pre-COVID-19 phase (3.40%), followed by the COVID-19 (2.26%) and Post-COVID-19 (2.46%) phases.</p><p><strong>Conclusions: </strong>NPIs implemented during the early COVID-19 pandemic effectively suppressed the transmission of respiratory pathogens and disrupted their seasonal patterns. However, some pathogens gradually resumed activity during the mid-to-late COVID-19 phase, leading to atypical outbreaks. Following NPI relaxation, multiple pathogens rebounded during the Post-COVID-19 phase, posing significant challenges for the healthcare system. These findings offer valuable insights for guiding public health strategies and optimizing the prevention and control of respiratory infections.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":8981,"journal":{"name":"BMC Infectious Diseases","volume":"25 1","pages":"833"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12210601/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12879-025-11215-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate the epidemiological characteristics of pediatric respiratory pathogens in Guangzhou, China, from 2018 to 2023 in the context of the COVID-19 Pandemic and to evaluate the impact of non-pharmaceutical interventions (NPIs) on the transmission dynamics and seasonal patterns of respiratory pathogens.

Methods: A retrospective analysis was conducted at Guangzhou Women and Children's Medical Center between January 2018 and December 2023. Pediatric patients who underwent the respiratory pathogens tests were enrolled in the study and divided into four groups by age: Infant group, Toddler group, Preschool group, and School-age group. The nasopharyngeal swab or bronchoalveolar lavage fluid (BALF) samples were collected for real-time fluorescence quantitative polymerase chain reaction (qPCR) test of respiratory pathogens. Ten common respiratory pathogens, including respiratory syncytial virus (RSV), Mycoplasma pneumoniae (MP) and Influenza A virus (FluA), were detected. In addition, the study period was divided into three phases: Pre-COVID-19 (2018-2019), COVID-19 (2020-2022), and Post-COVID-19 (2023). Detection rates, distribution patterns, and seasonal variations of respiratory pathogens were analyzed between different phases and different age groups.

Results: This study included 317,828 pediatric patients (median age: 3.4 years, IQR: 1.3-6.0), from whom 1,160,764 respiratory pathogen tests were conducted. The overall pathogen detection rate was 8.02% (93,108/1,160,764). The positive rate during the COVID-19 phase (18.44%, 95% CI 14.89-22.00%) was significantly lower than that of the Pre-COVID-19 (27.55%, 95% CI 23.95-31.16%) and Post-COVID-19 (27.15, 95% CI 21.47-32.84%) phases (P < 0.001). No significant difference was observed between Pre-COVID-19 and Post-COVID-19 phases (P = 0.948). Different pathogens exhibited varying levels of suppression and recovery patterns, with some demonstrating altered seasonal patterns. The primary affected age groups shifted from infants and toddlers during the Pre-COVID-19 and COVID-19 phases to preschool and school-age children in the Post-COVID-19 phase. Co-infections were identified in 2,515 cases, with the highest rate observed during the Pre-COVID-19 phase (3.40%), followed by the COVID-19 (2.26%) and Post-COVID-19 (2.46%) phases.

Conclusions: NPIs implemented during the early COVID-19 pandemic effectively suppressed the transmission of respiratory pathogens and disrupted their seasonal patterns. However, some pathogens gradually resumed activity during the mid-to-late COVID-19 phase, leading to atypical outbreaks. Following NPI relaxation, multiple pathogens rebounded during the Post-COVID-19 phase, posing significant challenges for the healthcare system. These findings offer valuable insights for guiding public health strategies and optimizing the prevention and control of respiratory infections.

Clinical trial number: Not applicable.

新冠肺炎大流行期间广州市儿童呼吸道病原体流行格局的变化
目的:了解2019冠状病毒病疫情背景下广州市2018 - 2023年儿科呼吸道病原体流行病学特征,评价非药物干预措施对呼吸道病原体传播动态和季节分布的影响。方法:回顾性分析广州市妇女儿童医疗中心2018年1月至2023年12月的病例。接受呼吸道病原体检测的儿科患者被纳入研究,并按年龄分为四组:婴儿组、幼儿组、学前班组和学龄组。采集鼻咽拭子或支气管肺泡灌洗液(BALF)标本,实时荧光定量聚合酶链反应(qPCR)检测呼吸道病原体。检测到呼吸道合胞病毒(RSV)、肺炎支原体(MP)和甲型流感病毒(FluA)等10种常见呼吸道病原体。此外,研究期间分为三个阶段:COVID-19前期(2018-2019),COVID-19(2020-2022)和COVID-19后(2023)。分析不同阶段、不同年龄组呼吸道病原菌检出率、分布规律及季节变化。结果:本研究纳入317,828例儿科患者(中位年龄:3.4岁,IQR: 1.3-6.0),其中进行了1,160,764例呼吸道病原体检测。总病原菌检出率为8.02%(93,108/1,160,764)。COVID-19阶段的阳性率(18.44%,95% CI 14.89 ~ 22.00%)显著低于COVID-19前(27.55%,95% CI 23.95 ~ 31.16%)和COVID-19后(27.15,95% CI 21.47 ~ 32.84%)阶段(P结论:COVID-19大流行早期实施的npi有效抑制了呼吸道病原体的传播,并破坏了其季节性模式)。然而,一些病原体在COVID-19中后期逐渐恢复活动,导致非典型暴发。在NPI放松之后,多种病原体在covid -19后阶段反弹,给医疗保健系统带来了重大挑战。这些发现为指导公共卫生战略和优化呼吸道感染的预防和控制提供了有价值的见解。临床试验号:不适用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Infectious Diseases
BMC Infectious Diseases 医学-传染病学
CiteScore
6.50
自引率
0.00%
发文量
860
审稿时长
3.3 months
期刊介绍: BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信